Better LATE Than Nothing: Some Comments on Deaton (2009) and Heckman and Urzua (2009)
نویسندگان
چکیده
منابع مشابه
Is something better than nothing?
In July 2000 I spent 3 weeks in Haiti on a medical student elective. Eager to work in a new country and experience a new culture, I’d read about Haitian culture and history. This was my first exposure to medicine outside of North America. People warned me: “Haiti? Be careful! You can’t trust anyone there! They’re so poor, they’ll take anything they can get their hands on!” I was confident commo...
متن کاملSomething is better than nothing.
b a c [ T w m v f s i m i y t c t Lesson 1. Doing something is better than doing nothing. “You should go to the studio everyday,” a University of ichigan art professor named Richard Sears told his stuents. “There’s no guarantee that you’ll make something ood—but if you don’t go, you’re guaranteed to make othing.” The same is true of science. Every research plan as flaws, often big obvious ones—...
متن کامل"Nobody does nothing better than a hospitalist".
But before we anticipate our future, let’s take a minute to refl ect on 2013. Read even a single issue from last year, and you’ll quickly get a picture of the things our community cares about and the questions we need to answer to improve the care of hospitalized children. To the outside observer, some of these questions might not look like much: the cost of an intravenous catheter placement, a...
متن کاملBetter Late Than Never
Some Prolog systems are able to delay the execution of Prolog goals and resume it later. We were involved in the design, implementation and evaluation of several such systems and we summarise here our experiences with them. First we describe a general structure of such ’coroutining’ systems and then we concentrate on the particular features of and choices made in three ECRC’s logic programming ...
متن کاملBetter late than never?
Although additional validation studies are needed, the data suggest that knowledge of circulating miRNAs such as miR-155 may someday be used to predict which patients with MBL go on to develop overt CLL. Importantly, the investigators looked at several types of specimens, including CLL cells and plasma from patients with CLL. Plasma miR-155 was as effective a biomarker as miR-155 isolated from ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Economic Literature
سال: 2010
ISSN: 0022-0515
DOI: 10.1257/jel.48.2.399